H

Healios K.K.

26 employees

Healios develops treatments for retinal diseases and age-related macular degeneration (AMD) using cell technology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
MultiStem
マザーズ
Stem cell
再生医薬品
Medical
iPS
再生医療
バイオベンチャー

Date founded

2011

Funding rounds raised

Total raised

$31M

from 5 investors over 5 rounds

H

Healios K.K. raised $31M on October 8, 2013

Investors: Dainippon Sumitomo Pharma, SNBL USA and Dogan, Inc.

H

Healios K.K. raised $214K on October 19, 2012

Investors: ｉＰＳアカデミアジャパン株式会社 and （株）アステム

FAQ